Femasys Inc. (FEMY) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Femasys Inc. (FEMY:NASDAQ), powered by AI.

Current Price
$4.18
Sector
Healthcare
What is the Femasys Inc. stock price forecast?

Femasys Inc. is currently trading at $4.18. View real-time AI analysis on Alpha Lenz.

What is Femasys Inc. insider trading activity?

View the latest insider trading data for Femasys Inc. on Alpha Lenz.

What is Femasys Inc.'s P/E ratio?

View Femasys Inc.'s valuation metrics on Alpha Lenz.

Femasys Inc.

NASDAQ · FEMY
$4.18-0.60(-12.55%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Femasys Inc.'s future dividend policy...
Alpha Chat Insight

Femasys Inc.'s ROE is -455.8%. Explore profitability and growth together.

Ask for details

Company Overview

Femasys Inc. is a medical device company committed to advancing women's healthcare solutions. The company specializes in developing and commercializing minimally invasive technologies that address various aspects of female reproductive health. Its product portfolio includes innovative devices for fertility, contraception, and cancer diagnosis. Femasys Inc. has made significant strides in the medical device industry through products such as FemVue, a diagnostic tool for fertility assessment, and FemBloc, an investigational permanent birth control solution. The company plays a critical role in the healthcare sector by providing specialized tools that enhance diagnostic accuracy and improve patient outcomes. Headquartered in Atlanta, Georgia, Femasys Inc. collaborates with healthcare professionals and institutions to deliver cutting-edge solutions that meet the unique needs of women globally. Through its commitment to innovation and patient care, Femasys contributes significantly to the advancement of reproductive health and the broader medical device market.

CEOMs. Kathy Lee-Sepsick M.B.A.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees69

Company Statistics

FY 2025

Profile

N/AMarket Cap
$2.29MRevenue
0.00Shares Out
69Employees

Margins

61.96%Gross
-746.48%EBITDA
-766.95%Operating
-812.21%Pre-Tax
-812.27%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

23.88%Rev 3Yr
17.18%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-112.32%ROA
-455.80%ROE
-100.91%ROIC

Financial Health

$9.27MCash & Cash Equivalents
$5.59MNet Debt
253.09%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Femasys Inc. (ticker: FEMY) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 69 employees.

The current price is $4.18 with a P/E ratio of -x and P/B of -x.

ROE is -455.80% and operating margin is -766.95%. Annual revenue is $2M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Femasys Inc. (FEMY) Stock Forecast 2026 $4.18 — Price, Financials & Analyst Targets | Alpha Lenz